India put a partial ban on the drug, touted March 25 by President Trump as a “game changer” in the U.S. response to COVID-19, to maintain an adequate supply for its own citizens.
The country put a total ban on exports on April 4, and in an April 6 news briefing, President Trump said he disagreed with the ban and threatened unspecified “retaliation” against India if it didn’t lift the ban, Business Insider reported.
The Indian government released a statement April 7 that didn’t mention President Trump’s comments but said it was partially lifting the ban in “appropriate quantities.”
Read the full article here.
More articles on pharmacy:
Gilead boosts remdesivir production, now has 1.5M doses
Walgreens adds 6 COVID-19 safety measures to protect workers
2 East Coast pharmacy schools graduating students early to fight COVID-19
